The same results were observed for lung cancer lines (A549) where treatment with TGF-β1 significantly decreased the gene expression of CDH1 (encoding E-cadherin), increased the gene expression of ACTA2 (encoding α-SMA) and VIM (encoding vimentin) [215]. Here, CDH1 is linked to lung carcinoma.